Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Quantum Biopharma Ltd. - Class B Subordinate Voting Shares
(NQ:
QNTM
)
14.29
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 4, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Quantum Biopharma Ltd. - Class B Subordinate Voting Shares
< Previous
1
2
3
4
5
Next >
InvestorNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) Completes Phase 1 Trial for MS Treatment, Reports Positive Safety Results
February 26, 2025
Via
Investor Brand Network
Quantum Biopharma Announces Completion of the Phase 1 Multiple Ascending Dose Clinical Trial for its Experimental Multiple Sclerosis Drug Lucid-21-302
February 26, 2025
From
Quantum BioPharma
Via
GlobeNewswire
Quantum BioPharma Continues to Diversify its Treasury with the Purchase of Another USD $1,000,000 Worth of Bitcoin (BTC) and Other Cryptocurrencies
February 18, 2025
From
Quantum BioPharma
Via
GlobeNewswire
BioMedNewsBreaks — Quantum BioPharma Ltd. (NASDAQ: QNTM) Engages MZ Group for Investor Relations Strategy
February 11, 2025
Via
Investor Brand Network
Quantum Biopharma Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communications Program
February 11, 2025
From
Quantum BioPharma
Via
GlobeNewswire
BioMedNewsBreaks — Quantum BioPharma Ltd. (NASDAQ: QNTM) Engages Enterprise Canada, Empire Market Ventures for PR, Investor Awareness
February 10, 2025
Via
Investor Brand Network
Quantum Biopharma Engages Enterprise Canada and Empire Market Ventures to Lead Public Communications and Investor Awareness Programs
February 10, 2025
From
Quantum BioPharma
Via
GlobeNewswire
Quantum BioPharma Heads For Best Week Ever — But Most Retail Traders Lament Missing Out On The Surge
February 07, 2025
The company has attracted heavy attention after its dietary supplement, Unbuzzd, showed that it can reduce blood alcohol concentration rapidly in a clinical trial.
Via
Stocktwits
Which stocks are moving on Thursday?
February 06, 2025
Let's have a look at what is happening on the US markets one hour before the close of the markets on Thursday. Below you can find the top gainers and losers in today's session.
Via
Chartmill
Quantum BioPharma Shares Are Up Over 80%: What's Going On?
February 06, 2025
Quantum BioPharma shares are surging Thursday after its licensee, Celly Nutrition, engaged a New York investment bank to raise up to $10 million and explore a potential U.S. initial public offering.
Via
Benzinga
On Thursday, there are stocks with unusual volume. Let's take a look.
February 06, 2025
Let's explore the current happenings on the US markets on Thursday. Below, you'll find the stocks exhibiting unusual volume in today's session.
Via
Chartmill
Thursday's session: top gainers and losers
February 06, 2025
Curious to know what's happening on the US markets in the middle of the day on Thursday? Join us as we explore the top gainers and losers in today's session.
Via
Chartmill
Thursday's session: gap up and gap down stocks
February 06, 2025
The market is filled with gapping stocks in Thursday's session. Let's discover which stocks are showing gap-ups and gap-downs.
Via
Chartmill
Dow Edges Higher; US Weekly Jobless Claims Increase
February 06, 2025
Via
Benzinga
Topics
Stocks
BioMedNewsBreaks — Quantum BioPharma Ltd. (NASDAQ: QNTM) Licensee Celly Nutrition Pursues $10M Capital Raise and U.S. IPO
February 06, 2025
Via
Investor Brand Network
Topics
Initial Public Offering
Which stocks are moving before the opening bell on Thursday?
February 06, 2025
Wondering what's happening in Thursday's pre-market session? Find an overview in this article.
Via
Chartmill
Quantum Biopharma Licensee Celly Nutrition Retains Leading New York Investment Bank to Advise on Capital Raise and Possible Initial Public Offering Following Highly Positive Results from unbuzzd™ Clinical Study
February 06, 2025
From
Quantum BioPharma
Via
GlobeNewswire
These stocks have an unusual volume in today's session
February 05, 2025
Discover the stocks with unexpected trading volume in today's session on the US markets.
Via
Chartmill
Top movers analysis one hour before the close of the markets on 2025-02-04: top gainers and losers in today's session.
February 04, 2025
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Via
Chartmill
Quantum BioPharma Shares Are Up Today: What's Going On?
February 04, 2025
Shares of Quantum BioPharma Ltd. (NASDAQ: QNTM) are soaring more than 70% on Tuesday after the company announced positive clinical trial results for its dietary supplement, unbuzzd, which accelerates...
Via
Benzinga
Gold Moves Higher; Estée Lauder Shares Slide
February 04, 2025
Via
Benzinga
Tuesday's session: top gainers and losers
February 04, 2025
Keep an eye on the top gainers and losers in Tuesday's session, as they reflect the most notable price movements.
Via
Chartmill
Nasdaq Surges Over 1%; Pfizer Earnings Top Estimates
February 04, 2025
Via
Benzinga
Traders are paying attention to the gapping stocks in Tuesday's session.
February 04, 2025
Let's have a look at the gap up and gap down stocks in today's session.
Via
Chartmill
BioMedNewsBreaks — Quantum BioPharma Ltd. (NASDAQ: QNTM) Reports Positive Clinical Trial Results for unbuzzd™
February 04, 2025
Via
Investor Brand Network
Quantum BioPharma Stock Soars As Unbuzzd Trial Shows Rapid Fall In Blood Alcohol Levels, Retail Frenzy Ensues
February 04, 2025
The company said it also led to a 67% reduction in headache severity at four hours and continued to ease cognitive and physical impairment up to eight hours after consumption.
Via
Stocktwits
US Stocks Mixed; PepsiCo Posts Downbeat Sales
February 04, 2025
Via
Benzinga
Discover the top movers in Tuesday's pre-market session.
February 04, 2025
Before the US market kicks off on Tuesday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.
Via
Chartmill
Quantum BioPharma Stock Is Soaring Tuesday: What's Driving The Action?
February 04, 2025
Quantum BioPharma Ltd (NASDAQ:QNTM) shares are rising Tuesday after the company announced positive clinical trial results for its unbuzzd dietary supplement.
Via
Benzinga
Quantum Biopharma Announces the Success of unbuzzd™ Clinical Trial
February 04, 2025
Trial Confirms unbuzzd™ Dramatically Accelerates Alcohol Metabolism, Speeds the Reduction of Blood Alcohol Concentration, and Reduces Symptoms of Intoxication, Impairment and Hangover
From
Quantum BioPharma
Via
GlobeNewswire
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.